HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mofezolac

Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Also Known As:
(3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid; (3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid; 3,4-DMPIAA; N 22 compound; N-22 compound
Networked: 16 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Perrone, Maria Grazia: 5 articles (10/2020 - 01/2017)
2. Scilimati, Antonio: 5 articles (10/2020 - 01/2017)
3. Ferorelli, Savina: 4 articles (10/2020 - 12/2017)
4. Fortuna, Cosimo G: 3 articles (10/2019 - 12/2017)
5. Vitale, Paola: 3 articles (02/2019 - 01/2017)
6. Kitamura, Tomohiro: 3 articles (10/2006 - 09/2002)
7. Matsuura, Mamoru: 3 articles (10/2006 - 09/2002)
8. Wakabayashi, Keiji: 3 articles (10/2006 - 09/2002)
9. Miciaccia, Morena: 2 articles (10/2019 - 02/2019)
10. Pati, Maria Laura: 2 articles (10/2019 - 02/2019)

Related Diseases

1. Neuroinflammatory Diseases
2. Carcinogenesis
3. Stroke (Strokes)
4. Colonic Neoplasms (Colon Cancer)
5. Aberrant Crypt Foci

Related Drugs and Biologics

1. Lipopolysaccharides
2. tallow
3. Cyclooxygenase 1
4. N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
5. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
6. Indomethacin (Indometacin)
7. Azoxymethane
8. 4- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamide
9. Therapeutic Uses
10. Neuroprotective Agents